Cas:12217-22-0 Acid Blue 183 manufacturer & supplier

We serve Chemical Name:Acid Blue 183 CAS:12217-22-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

Acid Blue 183

Chemical Name:Acid Blue 183
CAS.NO:12217-22-0
Synonyms:Acid Blue 183
Molecular Formula:N/A
Molecular Weight:N/A
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:
Exact Mass:
LogP:

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like Acid Blue 183 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Acid Blue 183 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Acid Blue 183 Use and application,Acid Blue 183 technical grade,usp/ep/jp grade.


Related News: The Branchburg factory first came under FDA scrutiny in late 2019, when agency inspectors began to document numerous quality control problems. By March, 2020, the FDA had deemed the manufacturing issues as “Official Action Indicated,” its most serious category of violation. Acid Blue 183 manufacturer Pharmaceutical intermediates: chemical raw materials or chemical products used in the process of pharmaceutical synthesis, are intermediate products in the process of producing APIs, and can be further processed into APIs. Acid Blue 183 supplier Commonly used generic drugs: the products whose patents have expired and the generic drugs of many companies have participated in the competition, and the market demand is large. Acid Blue 183 vendor Commonly used generic drugs: the products whose patents have expired and the generic drugs of many companies have participated in the competition, and the market demand is large. Acid Blue 183 factory The Branchburg factory first came under FDA scrutiny in late 2019, when agency inspectors began to document numerous quality control problems. By March, 2020, the FDA had deemed the manufacturing issues as “Official Action Indicated,” its most serious category of violation.